Insider · CIK 0001323190
Andrew K Balo
Files at GCTK (Glucotrack, Inc.). First filing -, latest -.
In brief
Andrew K Balo files SEC Form 4 as director at GCTK (Glucotrack, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Andrew K Balo has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 25, 2025 | GCTK Glucotrack, Inc. | AGrant or award Common Stock, par value $0.001 per share | +75 | $0.00 | $0 | 75 | Oct 7, 2025 |
| Jul 11, 2025 | GCTK Glucotrack, Inc. | AGrant or award Common Stock, par value $0.001 per share | +3,332 | $0.00 | $0 | 3,407 | Oct 7, 2025 |
| Oct 3, 2025 | GCTK Glucotrack, Inc. | AGrant or award Common Stock, par value $0.001 per share | +1,285 | $0.00 | $0 | 4,692 | Oct 7, 2025 |
| Oct 3, 2025 | GCTK Glucotrack, Inc. | AGrant or award Stock option (right to buy)derivative | +4,055 | $0.00 | $0 | 4,055 | Oct 7, 2025 |
| Mar 26, 2025 | GCTK Glucotrack, Inc. | AGrant or award Common Stock, par value $0.001 per share | +4,490 | $0.00 | $0 | 4,490 | Mar 28, 2025 |
Questions about Andrew K Balo
Answered from the filings on this page, as of the latest one.
Is Andrew K Balo buying or selling?
Andrew K Balo has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Andrew K Balo's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andrew K Balo has 0.
Where does Andrew K Balo file Form 4?
Andrew K Balo has filed Form 4 at GCTK (Glucotrack, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.